Copenhagen Respiratory Research
Copenhagen Respiratory Research
Explore linked clinical trials.5 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Inhaled Lexofloxacin vs Usual Care for Treatment of Community-Acquired Pneumonia | Community-Acquired Infections, Community-Acquired Pneumonia, Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Not yet recruiting | Phase 2 / Phase 3 | 2026-09-30 | NCT07843017 | |
| Vaccine Pandemic Preparedness Through Airway Immunology Characterization | Infections, RNA Virus Infections, influenza, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease | Active, not recruiting | Early phase 1 | 2026-03-25 | NCT05921448 | |
| Comparing Hydrocortisone and Prednisolone for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD) | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Phase 4 | 2026-03-18 | NCT06892210 | |
| Comparing Hydrocortisone and Prednisolone for Community Acquired Pneumonia (CAP) | Community-Acquired Infections, Community-Acquired Pneumonia, Infections, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Phase 4 | 2026-03-18 | NCT06892197 | |
| Local Antibiotic Delivery for Community Acquired Pneumonia | Chronic Disease, Community-Acquired Infections, Community-Acquired Pneumonia, Disease Attributes, Hypersensitivity, Immediate, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiratory Hypersensitivity, asthma, bronchial disorder, chronic obstructive pulmonary disease, immune system disorder, lung disorder, obstructive lung disease, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Not yet recruiting | Phase 2 / Phase 3 | 2025-03-10 | NCT06859450 |